دواعي استعمال نيومو 23 لقاح فاكسين 25 مكجم/0.5 مل

23-valent pneumococcal polysaccharide vaccine, 25 mcg/0.5 ml, for subcutaneous or intramuscular injection, by Sanofi Pasteur.

• Active immunization for prevention of pneumococcal disease caused by the 23 serotypes in the vaccine; approved in the US for persons 50 years or older and persons aged >=2 years at increased risk.DailyMed (U.S. National Library of Medicine)

• Most common (>10%) after first vaccination: injection-site pain/soreness/tenderness, injection-site swelling/induration, headache, injection-site erythema, asthenia/fatigue, myalgia.نشرة دولية لتركيبة مكافئة · DailyMed (U.S. National Library of Medicine)

• Severe allergic reaction (e.g., anaphylaxis) to any component of the vaccine.نشرة دولية لتركيبة مكافئة · DailyMed (U.S. National Library of Medicine)

• Available human data have not established the presence or absence of a vaccine-associated risk in pregnancy; no animal developmental toxicity studies.نشرة دولية لتركيبة مكافئة · DailyMed (U.S. National Library of Medicine)
• Not known whether excreted in human milk; consider benefits of breastfeeding with the mother's clinical need for the vaccine.نشرة دولية لتركيبة مكافئة · DailyMed (U.S. National Library of Medicine)